TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15381867

Group type: EXPERIMENTAL
Intervention: 99mTc ethyl cysteinate dimer SPECT with PVE correction
Number of subjects: 40
Study: 11527484

Group type: EXPERIMENTAL
Intervention: Four verbal prompts to drink per day for 16 weeks
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Eight verbal prompts per day for 8 weeks
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Eight verbal prompts per day for 8 weeks plus compliance with beverage preferences
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 63
Study: 9249120

Group type: EXPERIMENTAL
Intervention: ondansetron 4 mg
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: metoclopramide 10 mg
Number of subjects: 175

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 175
Study: 8499196

Group type: EXPERIMENTAL
Intervention: EMLA cream
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subcutaneous ring anaesthesia (SRA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single cuff (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Double cuff technique
Number of subjects: 0
Study: 3092968

Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 29473704

Group type: EXPERIMENTAL
Intervention: Exenatide QW + IG
Number of subjects: 464

Group type: COMPARATOR
Intervention: Placebo + IG
Number of subjects: 464
Study: 27557407

Group type: EXPERIMENTAL
Intervention: 5°C cold-water immersion
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 15°C cold-water immersion
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 42
Study: 24172641

Group type: EXPERIMENTAL
Intervention: Cryoultrasound therapy
Number of subjects: 102

Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 102
Study: 25470572

Group type: EXPERIMENTAL
Intervention: Methylphenidate hydrochloride extended-release (MPH-MLR) 15 mg daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Methylphenidate hydrochloride extended-release (MPH-MLR)
Number of subjects: 20
Study: 21847649

Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 499

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 499
Study: 18296966

Group type: EXPERIMENTAL
Intervention: Combined ballistic and heavy resistance training (COM)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Heavy resistance training (HR)
Number of subjects: 17
Study: 16804432

Group type: EXPERIMENTAL
Intervention: MMRV vaccine (one of 3 consistency lots)
Number of subjects: 3928

Group type: COMPARATOR
Intervention: MMR + V (administered at separate injection sites)
Number of subjects: 3928

Group type: EXPERIMENTAL
Intervention: MMRV vaccine
Number of subjects: 3928
Study: 14530872

Group type: EXPERIMENTAL
Intervention: 30 microk/kg PEG‐rHuMGDF as a single dose on day ‐6 (n=37)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 30 microk/kg PEG‐rHuMGDF administered on day ‐6 followed by 10 microg/kg on days ‐5 to day 6 (n=35)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo as a single dose on day ‐6 (n=9)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo administered on day ‐6 to day 6 (n=9)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: PEG‐rHuMGDF day ‐6 to 6 group
Number of subjects: 90
Study: 11030677

Group type: EXPERIMENTAL
Intervention: Routine speech and language therapy
Number of subjects: 159

Group type: COMPARATOR
Intervention: Watchful waiting
Number of subjects: 159
Study: 8865710

Group type: EXPERIMENTAL
Intervention: 7.2% hypertonic saline (HS)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Lactate Ringer's (LR)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Isotonic saline (NS)
Number of subjects: 24
Study: 1984187

Group type: EXPERIMENTAL
Intervention: Low-protein, low-phosphorus diet (0.6 g of protein per kg of ideal body weight per day, 500 to 1000 mg of phosphorus, 2000 mg of sodium)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control diet (at least 1 g of protein per kg per day, 1000 mg of phosphorus, 2000 mg of sodium)
Number of subjects: 35
Study: 6620853

Group type: EXPERIMENTAL
Intervention: Steroid treatment
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Chlorambucil or cyclophosphamide
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Initial response to steroid therapy
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Follow-up
Number of subjects: 29
Study: 30639610

Group type: EXPERIMENTAL
Intervention: Immediate coronary angiography
Number of subjects: 558

Group type: COMPARATOR
Intervention: Initial intensive care assessment with delayed/selective angiography
Number of subjects: 558
Study: 29214015

Group type: EXPERIMENTAL
Intervention: Spinal manipulative treatment (SMT)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 22
Study: 25692608

Group type: EXPERIMENTAL
Intervention: R‐AMPH (Evekeo, racemic amphetamine sulfate)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 24457846

Group type: EXPERIMENTAL
Intervention: THC:CBD oromucosal spray (Sativex®)
Number of subjects: 1000
Study: 22947544

Group type: EXPERIMENTAL
Intervention: Aerobic impact exercise training (3x/week)
Number of subjects: 86
Study: 19812130

Group type: EXPERIMENTAL
Intervention: Cervical collar
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Physiotherapy
Number of subjects: 205

Group type: COMPARATOR
Intervention: Wait and see policy (control)
Number of subjects: 205
Study: 17760536

Group type: EXPERIMENTAL
Intervention: Quadrant-wise basic periodontal therapy (BPT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Full-mouth scaling and root planing (FRP)
Number of subjects: 30
Study: 15082131

Group type: EXPERIMENTAL
Intervention: Post-operative pain management
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Classification of pain severity (mild, moderate, severe)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Long-term clinical trials of post-operative pain control
Number of subjects: 0
Study: 11853276

Group type: EXPERIMENTAL
Intervention: Aerobic exercise and health education program
Number of subjects: 72

Group type: COMPARATOR
Intervention: Regular health education and lumbar flexion exercise program
Number of subjects: 72
Study: 9691919

Group type: EXPERIMENTAL
Intervention: Imipramine (25 mg days 1‐3, 50 mg days 4‐6, 75 mg days 7‐12)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 8151910

Group type: EXPERIMENTAL
Intervention: SBT/CPZ monotherapy
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: SBT/CPZ combined with aminoglycoside (AMK, TOB, etc.)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: SBT/CPZ plus AMK
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: SBT/CPZ combined therapy
Number of subjects: 63
Study: 2905797

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44

Group type: COMPARATOR
Intervention: No pill
Number of subjects: 44
Study: 30946963

Group type: EXPERIMENTAL
Intervention: Tiotropium Handihaler (H) in summer (HS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tiotropium Handihaler (H) in winter (HW)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (HC)
Number of subjects: 0
Study: 28594056

Group type: EXPERIMENTAL
Intervention: Memantine plus atypical antipsychotic
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo plus atypical antipsychotic
Number of subjects: 64
Study: 26595964

Group type: EXPERIMENTAL
Intervention: Whole body cryotherapy
Number of subjects: 55

Group type: COMPARATOR
Intervention: Common mineral baths, physiotherapy, therapeutic physical exercises, spinal massage
Number of subjects: 55
Study: 23203977

Group type: EXPERIMENTAL
Intervention: Non-pharmacological interventions during heel-stick procedures
Number of subjects: 0
Study: 22089654

Group type: EXPERIMENTAL
Intervention: Toothbrushing with purified water (twice daily)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Mock oral care (twice daily)
Number of subjects: 53
Study: 18459553

Group type: EXPERIMENTAL
Intervention: Sodium phosphate (NaP)
Number of subjects: 343

Group type: COMPARATOR
Intervention: Polyethylene glycol-electrolyte lavage solution (PEG-ELS)
Number of subjects: 343
Study: 16298243

Group type: EXPERIMENTAL
Intervention: Galantamine (4 mg bid) for 7 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 14624153

Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b daily (3 million units) plus ribavirin
Number of subjects: 116

Group type: COMPARATOR
Intervention: Interferon alfa-2b thrice-weekly (3 million units) plus ribavirin
Number of subjects: 116
Study: 10963197

Group type: EXPERIMENTAL
Intervention: sirolimus 2 mg daily (n=284)
Number of subjects: 719

Group type: EXPERIMENTAL
Intervention: sirolimus 5 mg daily (n=274)
Number of subjects: 719

Group type: COMPARATOR
Intervention: azathioprine (n=161)
Number of subjects: 719
Study: 8931539

Group type: EXPERIMENTAL
Intervention: Normal subjects
Number of subjects: 16

Group type: COMPARATOR
Intervention: Prosthetic limb of amputee subjects
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Intact limb of amputee subjects
Number of subjects: 16
Study: 1565457

Group type: EXPERIMENTAL
Intervention: Subconjunctival mitomycin (MMC)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Postoperative subconjunctival injections of 5-fluorouracil (5-FU)
Number of subjects: 39
Study: 3885805

Group type: EXPERIMENTAL
Intervention: SealEasy mask (Respironics Inc, Monroeville, PA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Laerdal mask (old type)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Transparent Robertshaw mask with inflatable black rim
Number of subjects: 30
Study: 31812339

Group type: EXPERIMENTAL
Intervention: 268 mg α‐T
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 537 mg α‐T
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 263 mg TRF
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 526 mg TRF
Number of subjects: 10
Study: 31499405

Group type: EXPERIMENTAL
Intervention: Sensorimotor training (8 weeks, 3 days/week, 10 different types of exercises)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Sensorimotor training
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (diabetes and foot care education only)
Number of subjects: 37
Study: 29333776

Group type: EXPERIMENTAL
Intervention: SRP+L (Scaling and Root Planning with Nd: YAG laser)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: L+SRP (Nd: YAG laser followed by Scaling and Root Planning)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SRP (Scaling and Root Planning)
Number of subjects: 0

Group type: COMPARATOR
Intervention: C (No treatment)
Number of subjects: 0
Study: 26023221

Group type: EXPERIMENTAL
Intervention: High-Intensity Swimming (HIS)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Swimming (MOS)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Soccer (SOC)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 83
Study: 24647388

Group type: EXPERIMENTAL
Intervention: Whole blood (EDTA and heparin) stored with an icepack for 24 or 48 hours
Number of subjects: 591

Group type: EXPERIMENTAL
Intervention: Postmenopausal women
Number of subjects: 591

Group type: EXPERIMENTAL
Intervention: Patients with coronary heart disease
Number of subjects: 591
Study: 21926595

Group type: EXPERIMENTAL
Intervention: Mucus Shaver
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (standard endotracheal tube suctioning)
Number of subjects: 24
Study: 19636033

Group type: EXPERIMENTAL
Intervention: Intensive therapy (aimed for near-normal glycemic level with 3 or more daily insulin injections or an insulin pump)
Number of subjects: 1602

Group type: COMPARATOR
Intervention: Conventional therapy (1 to 2 daily insulin injections, not designed to achieve specific glycemic targets)
Number of subjects: 1602

Group type: COMPARATOR
Intervention: EDC cohort (observational study of patients with T1DM)
Number of subjects: 1602
Study: 17049803

Group type: EXPERIMENTAL
Intervention: Concerta
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Adderall XR
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 12710865

Group type: COMPARATOR
Intervention: Memantine 20 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Memantine 10 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Memantine
Number of subjects: 0
Study: 10868447

Group type: EXPERIMENTAL
Intervention: 75 mg/day of clopidogrel
Number of subjects: 36

Group type: COMPARATOR
Intervention: 325 mg/day of aspirin
Number of subjects: 36
Study: 8694311

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 246
Study: 1442126

Group type: EXPERIMENTAL
Intervention: Electrical intraneural stimulation at frequencies of 1, 2, 4, 10, and 15 Hz
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stimulus patterns mimicking nociceptor discharges
Number of subjects: 0
Study: 3902676

Group type: EXPERIMENTAL
Intervention: Fenquizone (10 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Chlorthalidone (25 mg)
Number of subjects: 20
Study: 30578003

Group type: COMPARATOR
Intervention: Habitual contact lens wear (HCL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Senofilcon A two-week replacement daily wear silicone hydrogel (OAS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Discontinued contact lens wear (SPEC)
Number of subjects: 30
Study: 30027269

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (200,000 IU initial bolus followed by 100,000 IU monthly)
Number of subjects: 5110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5110
Study: 26715500

Group type: EXPERIMENTAL
Intervention: Intravenous cefuroxime 1.5 g (group A)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (group B)
Number of subjects: 120
Study: 25345276

Group type: COMPARATOR
Intervention: Temperament and Character Inventory (TCI)
Number of subjects: 0
Study: 22493463

Group type: EXPERIMENTAL
Intervention: Colonoscopy
Number of subjects: 997
Study: 19573053

Group type: EXPERIMENTAL
Intervention: low-fat diet based on national dietary guidelines
Number of subjects: 891

Group type: EXPERIMENTAL
Intervention: low-fat diet low protein/low glycaemic index
Number of subjects: 891

Group type: EXPERIMENTAL
Intervention: low-fat diet low protein/high glycaemic index
Number of subjects: 891

Group type: EXPERIMENTAL
Intervention: low-fat diet high protein/low glycaemic index
Number of subjects: 891

Group type: EXPERIMENTAL
Intervention: low-fat diet high protein/high glycaemic index
Number of subjects: 891

Group type: COMPARATOR
Intervention: fixed low-energy diet (800 kcal) during 8-week weight-loss phase
Number of subjects: 891
Study: 18534808

Group type: EXPERIMENTAL
Intervention: Intravenous promethazine 25 mg
Number of subjects: 70

Group type: COMPARATOR
Intervention: Prochlorperazine 10 mg
Number of subjects: 70
Study: 16038473

Group type: EXPERIMENTAL
Intervention: Didanosine (ddI) for 4 weeks in addition to current combination therapy
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Jonckheere‐Terpstra test for trend
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Removing procedure
Number of subjects: 111

Group type: COMPARATOR
Intervention: Kruskal‐Wallis test
Number of subjects: 111
Study: 12372925

Group type: EXPERIMENTAL
Intervention: Ionic X-ray contrast agent (ioxaglate)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Non-ionic X-ray contrast agent (iopromide)
Number of subjects: 40
Study: 10365892

Group type: EXPERIMENTAL
Intervention: 30 mg lansoprazole
Number of subjects: 15

Group type: COMPARATOR
Intervention: 20 mg omeprazole
Number of subjects: 15
Study: 7856427

Group type: EXPERIMENTAL
Intervention: Paternal height
Number of subjects: 571

Group type: EXPERIMENTAL
Intervention: Paternal size (height and weight)
Number of subjects: 571

Group type: EXPERIMENTAL
Intervention: Paternal height (mean -2s.d.)
Number of subjects: 571
Study: 1951234

Group type: EXPERIMENTAL
Intervention: 40 mg bid famotidine
Number of subjects: 44

Group type: COMPARATOR
Intervention: Previous treatment with omeprazole
Number of subjects: 44
Study: 7038565

Group type: EXPERIMENTAL
Intervention: Metered aerosol dose of fenoterol
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Inhaled powder of fenoterol
Number of subjects: 11

Group type: COMPARATOR
Intervention: Aerosol inhalation
Number of subjects: 11

Group type: COMPARATOR
Intervention: Powder inhalation
Number of subjects: 11
Study: 31662381

Group type: EXPERIMENTAL
Intervention: FRESH intervention (family-based physical activity intervention delivered online)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pedometer-only (families receive pedometers and generic PA promotion information)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-intervention control
Number of subjects: 0
Study: 28758793

Group type: EXPERIMENTAL
Intervention: Tafamidis
Number of subjects: 93

Group type: COMPARATOR
Intervention: Tafamidis (after switching from placebo)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Tafamidis (in non-ATTRV30M patients)
Number of subjects: 93
Study: 26492879

Group type: EXPERIMENTAL
Intervention: Basic Body Awareness Therapy
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Mixed Physical Activity
Number of subjects: 310

Group type: COMPARATOR
Intervention: Treatment as Usual
Number of subjects: 310
Study: 24163324

Group type: EXPERIMENTAL
Intervention: Carbon nanoparticle suspension injection
Number of subjects: 72

Group type: COMPARATOR
Intervention: Conventional surgery (control group)
Number of subjects: 72
Study: 21196444

Group type: EXPERIMENTAL
Intervention: Intracoronary adenosine 4 mg
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study: 19644189

Group type: EXPERIMENTAL
Intervention: 500 mg of valacyclovir daily for 6 months
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: 500 mg of valacyclovir daily for 12 months
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: 500 mg of valacyclovir daily for 24 months
Number of subjects: 286

Group type: COMPARATOR
Intervention: Topical antiseptics (control group)
Number of subjects: 286
Study: 17684433

Group type: EXPERIMENTAL
Intervention: Epidural methylprednisolone (40 mg with 3 mL normal saline)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine (2 mL 5% with 2 mL normal saline)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Normal saline (4 mL)
Number of subjects: 150
Study: 12566642

Group type: EXPERIMENTAL
Intervention: Sodium monofluorophosphate (NaMFP) toothpaste
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Amine fluoride (AmF) toothpaste
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: AmF toothpaste and mouthwash
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: NaMFP toothpaste and varnish
Number of subjects: 104
Study: 10812906

Group type: EXPERIMENTAL
Intervention: Transposed cephalic vein fistula
Number of subjects: 23
Study: 7474044

Group type: EXPERIMENTAL
Intervention: 1 h continuous aerobic exercise (65% VO2 max)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 1 h intermittent anaerobic exercise (110% VO2 max)
Number of subjects: 9

Group type: COMPARATOR
Intervention: 1 h period of rest (control)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (1 h period of rest)
Number of subjects: 9
Study: 2015724

Group type: EXPERIMENTAL
Intervention: 1 gm acetaminophen
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1 gm acetylsalicylic acid
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 7235205

Group type: EXPERIMENTAL
Intervention: Microcrystalline theophylline tablet (Nuelin)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Sustained-release preparation (Nuelin Retard)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Both preparations
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Nuelin Retard preparation
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Twice-daily dosage of Nuelin Retard
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Side effects reported by three patients
Number of subjects: 13
Study: 31048420

Group type: EXPERIMENTAL
Intervention: PrenaBelt
Number of subjects: 200

Group type: COMPARATOR
Intervention: Sham-PrenaBelt
Number of subjects: 200
Study: 28426104

Group type: EXPERIMENTAL
Intervention: Amrubicin (35 mg/m2 on days 1-3 every 3 weeks)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Docetaxel (60 mg/m2 on day 1 every 3 weeks)
Number of subjects: 202
Study: 25440634

Group type: EXPERIMENTAL
Intervention: Multiple Electrode Aggregometry (MEA)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: TEG PlateletMapping (PM)
Number of subjects: 249

Group type: COMPARATOR
Intervention: None (control)
Number of subjects: 249
Study: 23770680

Group type: EXPERIMENTAL
Intervention: Tiagabine (TGB) at a median dose of 28 mg/day
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Tiagabine (TGB)
Number of subjects: 292
Study: 21300514

Group type: EXPERIMENTAL
Intervention: Enhanced interaction
Number of subjects: 719

Group type: EXPERIMENTAL
Intervention: Standard interaction
Number of subjects: 719

Group type: COMPARATOR
Intervention: No patient‐practitioner interaction
Number of subjects: 719
Study: 19108379

Group type: EXPERIMENTAL
Intervention: Lugua polypeptide injection (16 mg per day for 2 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Celecoxib (200 mg twice a day for 2 weeks)
Number of subjects: 50
Study: 16950462

Group type: EXPERIMENTAL
Intervention: Standard M-mode AVPD
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Color TD M-mode AVPD
Number of subjects: 56

Group type: COMPARATOR
Intervention: Pulsed TD
Number of subjects: 56
Study: 15608809

Group type: EXPERIMENTAL
Intervention: Green Prescription physical activity counselling programme (verbal advice and written exercise prescription with telephone follow-up)
Number of subjects: 878

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 878

Group type: EXPERIMENTAL
Intervention: Green Prescription physical activity counselling programme
Number of subjects: 878
Study: 10517718

Group type: EXPERIMENTAL
Intervention: Unconventional therapies
Number of subjects: 16068

Group type: COMPARATOR
Intervention: Conventional medical care
Number of subjects: 16068

Group type: EXPERIMENTAL
Intervention: Both unconventional therapies and conventional medical care
Number of subjects: 16068
Study: 7717834

Group type: EXPERIMENTAL
Intervention: Multidisciplinary team evaluation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Physiatrist evaluation
Number of subjects: 40